|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130 IDR | -1.52% |
|
-26.14% | -77.59% |
| 2023 | PT Indofarma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| 2023 | PT Indofarma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
PT Indofarma Tbk reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was IDR 1,144,108.23 million compared to IDR 2,901,986.53 million a year ago. Net loss was IDR 428,462.95 million compared to IDR 37,580.64 million a year ago.
Basic loss per share from continuing operations was IDR 138.25. Diluted loss per share from continuing operations was IDR 138.25.
| 1st Jan change | Capi. | |
|---|---|---|
| -77.59% | 24.84M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PT INDOFARMA TBK 
